Jimin Health plans to pay 409 million yuan in cash to acquire part of the partnership shares of CLP Huizhi, thereby indirectly holding 20.4550% of the shareholder equity of Great Wall Galaxy and enjoying 30% voting rights. Great Wall Galaxy is an integrated circuit design company. With March 31, 2026 as the appraisal base date, the book value of all its shareholders' equity was 579 million yuan, and the appraisal result under the income approach was 2.088 billion yuan, with an appraisal value increase of 1.509 billion yuan and an increase rate of 260.86%. In the first quarter of 2026, Great Wall Galaxy's net profit was negative 9.4572 million yuan, mainly due to the provision of 64.8731 million yuan for bad debts on accounts receivable from a major customer. Excluding this impact, the net profit was 47.6224 million yuan. Jimin Health stated that this investment will open up a high-value-added business track and enhance profitability and competitiveness.
Zhejiang Chimin Pharm Co LtdJimin Health plans to invest 409 million yuan to acquire stake in Great Wall Galaxy, an IC design company, aiming to open high-value-added business track and enhance profitability.